Journal of Substance Abuse Treatment

Papers
(The H4-Index of Journal of Substance Abuse Treatment is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
C2: editorial board123
JSAT call for papers for special issue: Stimulant use disorder85
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study85
Community perspectives on supervised consumption sites: Insights from four U.S. counties deeply affected by opioids75
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?60
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder57
Hepatitis C treatment outcomes among patients treated in co-located primary care and addiction treatment settings52
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail51
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts50
Augmenting substance use treatment in the drug court: A pilot randomized trial of peer recovery support50
Integrating substance use care into primary care for adolescents and young adults: Lessons learned49
The new services that opioid treatment programs have adopted in response to COVID-1949
C2: editorial board48
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders45
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data44
Views of barriers and facilitators to continuing methadone treatment upon release from jail among people receiving patient navigation services43
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail42
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up41
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis39
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments38
Education and careers were our way out36
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings35
C2: editorial board33
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration31
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation31
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study31
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)31
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam30
Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder30
Emergency department interventions for opioid use disorder: A synthesis of emerging models30
0.05902099609375